Efficacy of ORM-12741 on Agitation/Aggression Symptoms in Alzheimer's Disease
Status:
Completed
Trial end date:
2017-12-04
Target enrollment:
Participant gender:
Summary
This study evaluates the effect of ORM-12741 on agitation/aggression symptoms in Alzheimer's
disease. Two thirds of the patients will receive ORM-12741 and one third will receive
placebo.